Association Between Hyperuricemia and Metabolic Syndrome in a Senegalese Population

Fatou Cisse^*
*Correspondence: Fatou Cisse, Department of Odontostomatology, Cheikh Anta Diop University of Dakar, Senegal, Tel: 221776123465, Email:

Keywords

Hyperuricemia • Metabolic syndrome • Senegal

Introduction

Uric acid is the end product of purine metabolism in humans. Serum uric acid concentrations will therefore depend on the balance between intakes (endogenous and exogenous) and excretions. However, in a large number of cases, hyperuricemia results from a lack of renal elimination of uric acid associated or not with excessive food intake. Many studies have shown a relationship between high blood levels of uric acid and hypertension, obesity and hypertriglycideremia, which are components of the MS. This syndrome associated with a risk of diabetes and cardiovascular disease, is one of the most important public health problems in the world with a growing prevalence. The severity of this syndrome justifies early detection strategies based on the search for simple clinical, anthropometric and biological arguments in order to guarantee early management of this condition. Hyperuricemia, although not part of the criteria for defining the metabolic syndrome, is most often associated with its components; this is why, in this work, we set ourselves the objective of seeking a relationship between uric acid and SM.

Materials and Methods

This is a prospective study on 441 subjects received as part of a systematic annual visit to a Senegalese company involving administrative, technical and service staff; Included in the study were all subjects who had undergone a full clinical examination and blood tests provided for by this annual medical check-up (including blood sugar, lipid balance, uric acid).

Anthropometric data were collected on survey cards designed for this purpose. The biochemical parameters were measured using enzymatic methods adapted on the A15 analyser (Biosystems).

The SM was defined according to the criteria of (NCEP-ATP III): abdominal obesity (waist> 102 cm (men) and > 88 cm (women), high blood pressure (BP ≥ 130/85 mm Hg), hypertriglyceridemia (≥ 1.50 g/l), lower cholesterol HDL (<0.40 g/l (men) or <0.50 g/l (women)) and hyperglycemia (≥ 1.10 g/l); Subjects with at least three of these criteria were considered to have MS. Hyperuricemia has been defined as serum uric acid concentrations ≥ 72mg/l in men and ≥ 60mg/l in women.

All observations were entered and coded on Windows Excel 2010 (Microsoft, USA) and then analyzed using SPSS Statistics 24 (IBM, Chicago, IL, USA). Excel software was also used to present the tables, as well as to group the modalities of certain variables before their analysis.

Descriptive statistics presented the data in the form of tables. It then summarized the qualitative variables in the form of proportions (percentages) and the quantitative variables in the form of means +/- Standard Deviation.

For the qualitative variables, the comparison of the percentages required the Pearson chi-square test with Yates correction if necessary for small samples.

The statistical inference necessary for the analytical study was used to study the associations using statistical tests for the comparison of variables (Logistic regression) and an approximation of the relative risk using the Odds Ratio (OR) with a confidence interval 95% (95% CI). A risk value of the first kind α = 0.05 was considered as a significant threshold.

Results and Discussion

The average age of our study population was 38.82 ± 10.35 with a sex-ratio M/F of 1.12. The prevalence of MS and hyperuricemia were 6.57% and 6.34% respectively (Table 1). The prevalence of hyperuricemia was 41.38% in subjects with MS versus 23.35% in subjects without MS.

Table 1. Characteristics of the study population.

Hyperuricemia and MS were strongly associated (OR = 3.87, p = 0.007). The study of the relationship between hyperuricemia and the other components of MS has shown a strong association with hypoHDLemia (OR = 5.09), hypertriglyceridemia (OR = 3.05) and abdominal obesity (OR = 2.52). We also found a higher prevalence of hyperuricemia in subjects over 50 years with a male predominance.

Our study found a positive association between hyperuricemia and SM (OR = 2.29, p = 0.05). These results corroborate those of numerous epidemiological data and experimental. The relationship between uric acid levels and the risk of developing MS has been established by a meta-analysis of prospective studies. Indeed, hyperuricemia is a risk factor for MS. This could be explained by its constant association with the different components of the SM. In fact, in our study, significant associations were found between hyperuricemia and hypertension, abdominal obesity and dyslipidemia (Table 2). This is in agreement with the data of the literature. However, we have not found an association between hyperuricemia and hyperglycemia.

Table 2. Association between hyperuricemia and the various components of MS.

These results could be linked to the inhibitory action of glucose on the reabsorption of uric acid which thus promotes its excretion. This role of glucose cannot explain the high prevalence of hyperuricemia in type 2 diabetics found by some authors. According to the latter, hyperuricemia in diabetics was favored by the existence of an MS or one of its components.

The study of the distribution of hyperuricemia according to age and sex shows on the one hand an increase in the prevalence in subjects over 50 years and on the other hand higher rates in men compared women. The opposite being observed for the SM. These opposite trends could be linked to the biases introduced by the differences in population size in the subgroups. Increased uric acid with age has been reported by Woyesa. However, Fu and colleagues found no significant association between uric acid and age. As for the male predominance, it has been widely described in the literature.

Conclusion

A positive association has been found between hyperuricemia and SM in the Senegalese population. This demonstrates the value of measuring uric acid in subjects at risk. Further work will be required to demonstrate whether hyperuricemia is a cause or a consequence of MS.

Conflicts of Interest

The authors declare that they have no conflict of interest

Author's contribution

Fatou Cisse developed the study protocol and the data collection. Fatou Cisse, Tarik Lamkinsi and Souleymane Thiam contributed to the analysis of the results and the drafting of the final document. The methodology and the statistical analyzes were performed by Tarik Lamkinsi. All authors have read and approved the final version of the manuscript.

References

1. Avula, Naveen Reddy, Shenoy D. "Evaluation of Association of Hyperuricaemia with Metabolic Syndrome and Insulin Resistance." J Clinical Diag Res 10 (2016): 32-34.
2. Cameron, Adrian J, Magliano DJ, Zimmet PZ, and Welborn TA, et al. "The Metabolic Syndrome as a Tool for Predicting Future Diabetes: The AusDiab Study." J Internal Med 264 (2008): 177-186.
3. Carbone, Federico, Montecucco F, Mach F, And Pontremoli R, Et Al. "The Liver and the Kidney: Two Critical Organs Influencing the Atherothrombotic Risk in Metabolic Syndrome." Thromb Haemost 110 (2013): 940-958.
4. Cibickova, L, Langova K, Vaverkova H, and Kubickova V, et al. "Correlation of Uric Acid Levels and Parameters of Metabolic Syndrome." Physiol Res 66 (2017): 481.
5. Conen, David, Wietlisbach V, Bovet P, and Shamlaye C, et al. "Prevalence of Hyperuricemia and Relation of Serum Uric Acid with Cardiovascular Risk Factors in a Developing Country." BMC Public Health 4 (2004): 1-9.